Allenbach et al proposed 3 types of anti-MDA5 antibody-positive DM with different prognoses.[12] One group (18.1%) corresponded to patients with rapidly progressive ILD and a very high mortality rate. This evidence concerns the gene IFIH1 and dermatomyositis.